Stay updated with breaking news from Sarepta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Global Gene and Cell Therapies Targeting CNS Disorders market is expected to reach a CAGR of 31.4 % during a forecast period of 2022-2030.
New management at IntegriCo looks to put the company — a maker of railroad ties produced using recycled plastics — back on track.
Global Antisense Oligonucleotide Therapeutics Market was valued at US$ 21.91 Billion in 2021. It is expected to reach US$ 64.64 Billion by 2030,a CAGR of 12.9 %
WASHINGTON (dpa-AFX) - Genetic medicine maker Sarepta Therapeutics, Inc. (SRPT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on SRP-5051 (vesleteplirsen)
Well over 2 000 signatures have been obtained in a petition objecting to the relocation of illegal occupants residing in the Passenger Rail Agency of South Africa’s (Prasa) railway reserve in Khayelitsha to Macassar and Sandvlei.